US SEC Filings Daily Market Digest — September 15, 2026

15-09-2026

Coca-Cola Europacific Partners plc (CCEP) announced the resignation of Independent Non-executive Director Nathalie Gaveau, effective 16 September 2026, after serving since January 2019. Mary Harris will serve as interim member of the Affiliated Transaction Committee, and the Nomination Committee has begun a process to appoint a new independent non-executive director. The change is a routine board governance update with no financial impact disclosed.

• · Nathalie Gaveau served as INED since January 2019 and was a member of the Affiliated Transaction Committee and the ESG Committee (2019-2025).
• · Mary Harris appointed interim member of the Affiliated Transaction Committee effective 16 September 2026.
• · Nomination Committee is reviewing board composition and has begun process to appoint a new independent non-executive director per CCEP's Articles of Association and Shareholders' Agreement.
• · CCEP is listed on Euronext Amsterdam, NASDAQ, London Stock Exchange, and Spanish Stock Exchanges; constituent of NASDAQ 100 and FTSE 100 (symbol CCEP, ISIN GB00BDCPN049).

15-09-2026

Ecopetrol S.A. filed a Form 6-K with the SEC for the month of September 2026, signed by CFO Alfonso Camilo Barco. The filing is a routine foreign issuer report and contains no financial results, operational updates, or material events.

15-09-2026

XCF Global, Inc. filed a universal shelf registration statement on Form S-3 with the SEC on September 14, 2026, to register up to $300,000,000 in securities for future offerings. The company, which focuses on sustainable aviation fuel (SAF) and renewable fuels, also disclosed a pending business combination with DevvStream Corp. and Southern Energy Renewables Inc., expected to close after stockholder meetings scheduled for September 10, 2026. The filing highlights the company's status as an emerging growth company and smaller reporting company, allowing reduced disclosure requirements.

• · The shelf registration statement was filed on September 14, 2026, and the prospectus date is blank (to be filled in).
• · XCF Global has not sold any securities pursuant to General Instruction I.B.6 of Form S-3 during the prior 12-calendar month period ending on the date of the prospectus.
• · The company completed the Prior Business Combination on June 6, 2025, involving Focus Impact BH3 Acquisition Company and Legacy XCF.
• · Legacy XCF was incorporated on January 20, 2023.
• · The New Rise Acquisitions were completed on January 23, 2025 and February 19, 2025.
• · The pending Business Combination with DevvStream and Southern Energy is subject to stockholder approval and other customary closing conditions, with special meetings scheduled for September 10, 2026.
• · XCF Global is an emerging growth company and a smaller reporting company, allowing exemptions from certain reporting requirements.

15-09-2026

On September 9, 2026, Anantha Ramamurti resigned from the board of directors of GSR IV Acquisition Corp., effective immediately, but will remain as President and Chief Financial Officer. The departure is a routine board change for a blank-check company, with no financial impact disclosed.

• · Mr. Ramamurti's resignation was effective September 9, 2026, and he remains President and CFO.
• · The company is an emerging growth company and a shell company (blank check).
• · Securities traded on NASDAQ: Units (GSRFU), Class A ordinary shares (GSRF), Rights (GSRFR).

15-09-2026

Lanvin Group Holdings Ltd filed its semi-annual report (6-K) with the SEC for the six months ended June 30, 2026. The filing includes unaudited financial statements and disclosures for the period. Key financial metrics, including revenue, profitability, and segment performance, are detailed in the attached exhibit.

• · The report is filed as a Form 6-K for the month of September 2026.
• · The filing incorporates by reference into certain F-3 registration statements.
• · The address of principal executive offices is 4F, 168 Jiujiang Road, Carlowitz & Co, Huangpu District, Shanghai 200001, China.
• · The commission file number is 001-41569.

15-09-2026

Calor Del Sol Inc. filed a Form 12b-25 Notification of Late Filing (NT 10-Q) with the SEC on September 15, 2026, indicating that its Form 10-Q for the fiscal quarter ended July 31, 2026, will be delayed. The company cites delays in completing its financial statements for the fiscal year ended July 31, 2026, as the reason. The filing does not anticipate any significant change in results of operations from the prior year period.

• · The company has not filed any other periodic reports late in the preceding 12 months (all reports were filed on time).
• · The company does not anticipate any significant change in results of operations from the corresponding prior-year period.
• · The Form 10-Q is due within 5 calendar days of the prescribed due date (per Rule 12b-25(b)).
• · The notification was signed on September 14, 2026, one day before the filing date.

15-09-2026

Iridium Communications Inc. entered into a Fourth Amendment to its Credit Agreement to facilitate its pending acquisition by Rocket Lab Corporation. The amendment ensures the transaction does not trigger a change of control under the credit facility, allows existing term loans to remain outstanding post-closing, and introduces higher interest rates and fees effective after the merger closes. The definitive proxy statement/prospectus was filed on August 26, 2026, and Iridium stockholders are being solicited for approval.

• · The Fourth Amendment was entered into on September 15, 2026.
• · The amendment provides for a downstream guarantee of credit obligations by Rocket Lab USA, Inc. at closing.
• · The interest rate increase and new fees (prepayment premium and exit fee) take effect only after the transaction closes.
• · The definitive proxy statement/prospectus was declared effective by the SEC on August 26, 2026.
• · Stockholder solicitation began on or about August 26, 2026.

15-09-2026

Atkore Inc. announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act has expired as of September 14, 2026, clearing a key regulatory hurdle for its proposed acquisition by Prysmian S.p.A. The merger remains subject to other conditions, including stockholder approval and additional regulatory clearances. The definitive proxy statement was mailed to stockholders on September 9, 2026.

• · The HSR Act waiting period expired effective 11:59 p.m. Eastern Time on September 14, 2026.
• · HSR Act notifications were filed on August 14, 2026.
• · The Merger Agreement was entered into on August 2, 2026.
• · The definitive proxy statement was first mailed to stockholders on or around September 9, 2026.
• · The merger requires adoption by the affirmative vote of holders of a majority of outstanding shares of common stock entitled to vote.

15-09-2026

Grab Holdings Ltd announced it will acquire a majority stake in Atome Financial, a buy-now-pay-later and digital financial services platform in Southeast Asia. The acquisition expands Grab's fintech capabilities and user base in the region. No financial terms or expected closing timeline were disclosed in the filing.

• · The filing is a Form 6-K for the month of September 2026.
• · The acquisition target is Atome Financial, a buy-now-pay-later and digital financial services platform.
• · The filing is incorporated by reference into Grab's existing F-3 registration statements (Nos. 333-261949 and 333-264872).

15-09-2026

Equinor ASA disclosed weekly buy-back transactions under the third tranche of its 2026 share buy-back programme, purchasing 683,570 shares on the Oslo Stock Exchange (OSE) between 7 and 11 September 2026 at a weighted average price of NOK 406.9977, for a total of NOK 278,211,409.06. Accumulated buy-backs under the tranche reached 5,032,090 shares for NOK 1,965,568,991.57. The daily weighted average price rose from NOK 397.7815 to NOK 416.9702 before easing to NOK 411.8487, while daily volumes declined from 138,762 to 134,000 shares.

• · Daily weighted average price peaked at NOK 416.9702 on 10 September, up from NOK 397.7815 on 7 September.
• · Daily volume declined from 138,762 shares on 7 September to 134,000 shares on 11 September.
• · Previously disclosed buy-backs under the tranche totaled 4,348,520 shares for NOK 1,687,357,582.51.
• · All transactions were executed on the Oslo Stock Exchange (OSE); no transactions were reported on CEUX or TQEX.

15-09-2026

ING Groep N.V. filed a Form 6-K with the SEC on September 15, 2026, attaching a press release issued the same day. The filing is a routine foreign issuer report and does not contain any financial results, material transactions, or regulatory actions.

• · The press release is attached as Exhibit 99.1 but its content is not disclosed in the filing.
• · The filing is made under Commission File Number 001-14642.

15-09-2026

Korea Electric Power Corp (KEP) reported mixed financial results for H1 2026. Consolidated sales were essentially flat at ₩46,317 billion (up 0.3% from ₩46,174 billion in H1 2025), while operating profit declined 16.6% to ₩4,913 billion from ₩5,889 billion, and net income fell 20.9% to ₩2,797 billion. The thermal generation segment swung to an operating loss of ₩246 billion from a profit of ₩565 billion, though nuclear generation operating profit rose 28.9% to ₩3,089 billion. Total assets increased 3.0% to ₩262,561 billion, while total liabilities rose 2.5% to ₩210,716 billion. Dividend payments for FY2025 were ₩1,542 per share, totaling ₩989.9 billion.

• · Electricity sales segment operating profit declined to ₩2,123 billion from ₩2,857 billion (down 25.7%).
• · Thermal generation sales increased to ₩13,479 billion from ₩13,052 billion, but operating profit swung to a loss of ₩246 billion from a profit of ₩565 billion.
• · Nuclear generation operating profit rose to ₩3,089 billion from ₩2,396 billion (up 28.9%), while sales were nearly flat at ₩8,152 billion.
• · Plant maintenance & engineering service operating profit increased to ₩142 billion from ₩121 billion (up 17.4%).
• · Separate (parent-only) sales declined to ₩44,996 billion from ₩45,461 billion (down 1.0%), and separate operating profit fell to ₩2,123 billion from ₩2,857 billion (down 25.7%).
• · Cash and cash equivalents increased to ₩2,622,064 million from ₩2,240,811 million (up 17.0%).
• · Current financial liabilities rose to ₩50,707,759 million from ₩45,939,089 million (up 10.4%).
• · Non-current financial liabilities decreased slightly to ₩82,735,285 million from ₩83,995,702 million (down 1.5%).
• · Retained earnings increased to ₩30,412,794 million from ₩28,500,584 million (up 6.7%).

15-09-2026

On September 15, 2026, Ingram Micro Holding Corp held a Capital Market Day, reaffirming its Q3 FY2026 guidance and releasing long-term targets. The company issued a press release and hosted a live webcast of the event. No specific financial figures or performance trends were disclosed in this filing.

• · The filing is an 8-K with Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits).
• · The company reaffirmed Q3 FY2026 guidance and provided long-term targets at the Capital Market Day.
• · The Investor Day webcast began at 10:15 a.m. Central Time on September 15, 2026.

15-09-2026

Hub Group announced preliminary, unaudited Q1 and Q2 2026 results, projecting consolidated operating revenue of $1.70B–$1.80B for the first half, but expects an operating loss before one-time charges due to higher fuel, rail, and drayage costs, excess capacity in Consolidation and Fulfillment, and incremental restatement costs. The company also disclosed that it expects a Nasdaq Staff Delisting Determination due to delayed filings, though it will appeal and seek a stay. Management initiated a new efficiency program and amended its credit agreement to extend financial statement delivery deadlines to November 30, 2026.

• · The company expects to receive a Staff Delisting Determination from Nasdaq due to delayed filings, but trading will not be suspended immediately; it will appeal and seek a stay.
• · The credit agreement amendment extends the deadline for delivering audited annual and quarterly financial statements to November 30, 2026, and allows restatement-related costs to be added back to EBITDA for covenant calculations.
• · The company expects to complete restatement filings in Q4 2026, including Form 10-K for 2025 and Forms 10-Q for Q1 and Q2 2026.
• · ITS revenue benefited from stable volumes and tightening capacity, but operating results were hurt by higher costs before rate increases in Q3 2026.
• · Logistics revenue benefited from new Final Mile business, but Managed Transportation saw modest revenue declines and Brokerage revenue/volume declined due to profitability focus.
• · Consolidation and Fulfillment revenue was negatively impacted by customer attrition.
• · The company expects an operating loss for H1 2026 before one-time charges.
• · Full year 2026 revenue estimate is $3.6B–$3.8B, with capex of $40M–$50M.

15-09-2026

Beazer Homes USA, Inc. (BZH) is holding a special meeting on October 15, 2026, to seek stockholder approval of a merger agreement with DFH and Merger Sub, dated August 6, 2026. The Board unanimously recommends voting FOR the merger, the advisory compensation proposal, and any adjournment. Stockholders who do not vote will effectively vote AGAINST the merger, and appraisal rights are available under Delaware law.

• · Special Meeting to be held exclusively online at 8:00 a.m. Eastern Time on October 15, 2026, at www.virtualshareholdermeeting.com/BZH2026SM
• · Record date for the Special Meeting is September 14, 2026
• · Merger Agreement dated August 6, 2026
• · Approval requires affirmative vote of stockholders holding a majority of outstanding shares of Company Common Stock
• · Failure to vote will have the same effect as a vote AGAINST the merger
• · Appraisal rights available under Delaware law for stockholders who meet certain requirements
• · Proxy materials first mailed on or about September 15, 2026
• · Proxy solicitor: MacKenzie Partners, Inc., toll-free +1 (800) 322-2885

15-09-2026

Profusa, Inc. received a Nasdaq compliance determination letter confirming it has regained compliance with the Bid Price Rule and Equity Rule. However, the company is now subject to a one-year Mandatory Panel Monitor period, during which any future non-compliance with the Equity Rule would result in immediate delisting proceedings without a cure period. The company also disclosed a potential option to acquire G3 Vision Labs, Inc., which would transform it into a public diagnostics company.

• · The compliance determination was issued on September 9, 2026.
• · The company regained compliance with Nasdaq Listing Rule 5550(a)(2) (Bid Price Rule) and 5550(b)(1) (Equity Rule).
• · During the one-year Monitoring Period, any failure to satisfy the Equity Rule will result in a Staff Delisting Determination without the opportunity to submit a compliance plan.
• · The company may appeal a delisting determination by requesting a hearing, which would stay further action until the hearing and any Panel extension expire.
• · Profusa has an option agreement to acquire G3 Vision Labs, Inc., subject to conditions, and upon exercise expects to operate as a public diagnostics company.
• · The company's common stock trades on Nasdaq under the symbol PFSA.

15-09-2026

Artificial Intelligence Technology Solutions Inc. (AITX) filed a Form 8-K on September 15, 2026, to announce a press release titled 'AITX's RAD Calls for Clear Boundaries in the Age of AI-Powered Security.' The filing is furnished under Item 8.01 and includes the press release as Exhibit 99.1. No financial figures or operational metrics were disclosed in this filing.

• · The press release is titled 'AITX's RAD Calls for Clear Boundaries in the Age of AI-Powered Security' and is attached as Exhibit 99.1.
• · The filing is furnished under Item 8.01 and is not deemed 'filed' for Section 18 of the Exchange Act purposes.
• · The company's principal executive offices are located at 10800 Galaxie Avenue, Ferndale, Michigan, 48220.

15-09-2026

This filing is a Form 6-K submitted by GSK plc (GLAXF) to the SEC on September 15, 2026. It contains no financial results, business updates, or material events; it merely lists the company's media and investor relations contacts. No quantitative data or performance indicators are provided.

• · Filing contains only contact information for media and investor relations teams.
• · No financial figures, strategic updates, or regulatory actions are disclosed.

15-09-2026

Tower Semiconductor (TSEM) announced its participation in ECOC 2026 on September 21-23, 2026 in Malaga, Spain, where it will showcase its high-volume Silicon Photonics and SiGe BiCMOS solutions targeting AI infrastructure, telecom, and emerging applications. The filing is a routine foreign issuer report and contains no financial results.

• · ECOC 2026 takes place September 21–23, 2026 at FYCMA, Malaga, Spain, booth #C1014.
• · Tower's SiPho platform is used for datacenter and telecom optical transceivers, NPO/CPO for AI clusters, DWDM lasers, optical circuit switching, FMCW LiDAR for Physical AI, and quantum computing.
• · Tower owns one 200mm facility in Israel, two 200mm facilities in the U.S., and through 51% holdings in TPSCo, two facilities in Japan (200mm and 300mm). It also shares a 300mm facility in Agrate, Italy with STMicroelectronics.

15-09-2026

BHP Group Ltd issued its Notice of Meeting for the 2026 Annual General Meeting (AGM) to be held on 22 October 2026. The filing highlights strong FY2026 financial results: attributable profit rose to US$9.8B (from US$9.0B in FY2025), underlying EPS increased to 260.0 USc (from 200.2 USc), and dividends totaled 172 USc per share (up from 110 USc), representing a total distribution of US$8.7B. However, the period was overshadowed by a fatal contractor incident at the Peak Downs mine, and safety metrics showed mixed trends—the high potential injury frequency (HPIF) improved to 0.07 from 0.09, but the total recordable injury frequency (TRIF) remained flat at 4.5. The Board recommends voting against the election of external candidate Stephen Mayne (Item 12) and recommends voting in favor of all other items except Item 15 (no recommendation).

• · Copper contributed more than half of Underlying EBITDA for the first time; BHP produced ~2 Mt of copper for the second consecutive year.
• · WAIO remained the lowest-cost major iron ore producer globally for the seventh consecutive year.
• · BMA steelmaking coal production increased ~10% over the past two years.
• · Jansen Stage 1 potash project is 84% complete; first potash on track for mid-CY2027.
• · Total economic contribution US$50.8B, including US$12.4B in payments to governments.
• · BHP remains one of the largest corporate taxpayers in Australia and Chile.
• · The Board recommends voting against Item 12 (election of Stephen Mayne) and makes no recommendation on Item 15 (leaving entitlements).
• · CEO Brandon Craig's LTIP performance period is 1 July 2026 to 30 June 2031, with vesting based on TSR relative to MSCI World Metals and Mining and MSCI World indices.
• · FY2026 dividend of 172 USc per share is the highest full-year dividend in four years.
• · A fatal contractor incident occurred at BMA's Peak Downs mine in July 2026.

15-09-2026

Novo Nordisk disclosed weekly share repurchase activity under its ongoing buyback programme, purchasing 1,050,000 B shares between 7 and 11 September 2026 at an average price of DKK 289.92, for a total transaction value of DKK 304,412,195. Cumulative purchases under the programme reached 18,325,000 B shares for DKK 5,526,186,488. The average purchase price declined over the week from DKK 297.98 to DKK 278.62, reflecting a downward trend in the share price.

• · Daily repurchases were consistent at 210,000 B shares each trading day from 7 to 11 September 2026.
• · Average purchase price declined each day, from DKK 297.98 on 7 September to DKK 278.62 on 11 September 2026.
• · Transaction value per day declined from DKK 62,576,264 on 7 September to DKK 58,509,613 on 11 September 2026.

15-09-2026

InnSuites Hospitality Trust (IHT) received notice from NYSE American that its compliance plan has been accepted, granting a plan period through December 24, 2027 to regain compliance with continued listing standards. The Trust is currently not in compliance but its listing continues under an extension. While the Trust recently increased stockholders' equity by $3 million as a step toward compliance, there is no assurance that it will meet the deadline or maintain compliance, and delisting proceedings could be initiated if progress is insufficient.

• · The notice was received on September 10, 2026, and the 8-K was filed on September 11, 2026.
• · The compliance plan was accepted by NYSE Regulation, and the plan period deadline is December 24, 2027.
• · If the Trust does not make progress consistent with the plan during the plan period, delisting proceedings could be initiated.
• · The Trust may appeal a staff delisting determination in accordance with Section 1010 and Part 12 of the Company Guide.
• · The Trust is considering capital-raising transactions, debt or capitalization restructuring, strategic transactions, reduction or deferral of certain cash uses, and operational initiatives to improve hotel gross operating profits.
• · Any actions remain subject to board or committee approval, accounting confirmation, NYSE American requirements, securities law compliance, and other conditions.

15-09-2026

Hyperliquid Strategies Inc (PURR) filed an S-1 registration statement on September 15, 2026, detailing its business combination with Sonnet BioTherapeutics Holdings, Inc. and Rorschach I LLC, which closed on December 2, 2025. The company was formed to acquire HYPE tokens, the native digital asset of the Hyperliquid decentralized protocol. The filing provides financial information for the fiscal year ended June 30, 2026, and includes pro forma data as of September 30, 2025, but no period-over-period comparisons are available in the provided content.

• · The business combination involved a reverse recapitalization where HSI acquired all outstanding stock of Rorschach on December 2, 2025.
• · Sonnet BioTherapeutics Holdings, Inc. entered into the Transaction Agreement on July 11, 2025.
• · Rorschach was formed on June 13, 2025, and had no business operations prior to the closing.
• · The company's strategy is to acquire HYPE tokens, the native digital asset of the Hyperliquid decentralized protocol.
• · No modifications have been updated since February 17, 2026, except as set forth in the filing.

15-09-2026

Maison Solutions Inc. filed a Form 12b-25 Notification of Late Filing for its quarterly report on Form 10-Q for the period ended July 31, 2026, citing the need for additional time to complete financial statement preparation and the independent auditor's review. The company expects to file the report within the five-day extension period. Notably, the company also disclosed that it has not yet filed its Annual Report on Form 10-K for the fiscal year ended April 30, 2026, indicating ongoing reporting delays.

• · The company has not filed its Annual Report on Form 10-K for the fiscal year ended April 30, 2026, as of the date of this notification.
• · The filing is for the quarterly period ended July 31, 2026.
• · The company anticipates filing the Form 10-Q within the five-day extension period provided by Rule 12b-25.

15-09-2026

Creatd, Inc. filed an S-1 registration statement on September 15, 2026 for a proposed IPO. The filing details numerous stock issuances during 2024-2025, including shares for debt conversions, liability settlements, and acquisitions, often at large discounts to face value resulting in losses on settlement. The company acquired Flewber Global, Inc. in February 2025, issuing 52,807 shares with a fair value of $950,526.

• · Company has undergone multiple name changes, formerly Jerrick Media Holdings, Inc., Great Plains Holdings, Inc., and LILM, Inc.
• · Many stock issuances for debt and liability settlements resulted in significant losses (e.g., $43,500 loss on $54,000 note conversion in Nov 2024, $40,857 loss on $41,429 note conversion in Sep 2024).
• · In 2024, the company rescinded 69,263 shares previously issued for employee/consultant pay, reinstating $881,304 of liabilities.
• · The acquisition of Flewber Global, Inc. in Feb 2025 included purchases by 13 investors of 13,807 common shares for $276,140.
• · Common stock issuance prices varied widely from $5.20 to $160.00 per share in 2024, indicating volatile valuation.
• · Series H Preferred shares issued in Oct 2024 have anti-dilution conversion price adjustment provisions.

15-09-2026

FatPipe, Inc. (NASDAQ: FATN) announced the appointment of Kanishka Ragula as Chief Financial Officer, effective September 11, 2026. Ragula, who previously served as Director of Finance at FatPipe and worked in J.P. Morgan's Technology Investment Banking group, brings M&A, capital markets, and technology experience. Eric Sherb will continue to advise the company in a consulting capacity to support the transition.

• · Kanishka Ragula graduated Summa Cum Laude from the University of Pennsylvania's Jerome Fisher Program in Management & Technology (M&T), earning a BS in Economics from Wharton and a BS in Engineering in Computer and Information Science from Penn Engineering.
• · Ragula held FINRA Series 79 and Series 63 registrations and completed the Securities Industry Essentials examination.
• · Ragula's capital markets experience included StubHub's IPO preparations (J.P. Morgan as Lead Left Bookrunner) and PagerDuty's $350 million convertible senior notes placement.
• · Ragula previously served as Director of Finance at FatPipe, involved in financial operations, strategic planning, investor activities, and growth initiatives.
• · Eric Sherb will continue to advise FatPipe in a consulting capacity to support an orderly transition.

15-09-2026

Odyssey Marine Exploration Inc. filed an S-4/A registration statement on September 14, 2026, related to a proposed merger with AOM and CIC Limited. The filing presents selected historical financial information for all three entities. Odyssey's financials show a net loss of $43,085,185 for the year ended December 31, 2025, compared to net income of $15,657,934 in 2024, and a net loss of $8,962,441 for the six months ended June 30, 2026, versus a net loss of $12,606,393 in the prior-year period. AOM, formed on May 9, 2025, had no revenues and a net loss of $54,797 for the period from May 9, 2025 to December 31, 2025, and a net loss of $54,797 for the six months ended June 30, 2026.

• · Odyssey's total stockholders' deficit was $37,648,703 as of December 31, 2025, compared to $16,244,561 as of December 31, 2024, and $41,741,820 as of June 30, 2026.
• · Odyssey's cash and cash equivalents decreased from $4,791,743 as of December 31, 2024 to $3,515,881 as of December 31, 2025, and further to $2,348,104 as of June 30, 2026.
• · AOM was formed on May 9, 2025, and had no revenues for the periods presented.
• · The filing is a proxy statement/prospectus related to a merger involving Odyssey, AOM, and CIC Limited, with pro forma effects not reflected in the historical financial information.

15-09-2026

Impact Biomedical Inc. (NYSE: IBO) announced a 1-for-12.62 reverse stock split effective September 23, 2026, to support its proposed merger with Zoar Limited (f/k/a Dr Ashleys Limited) and to help regain NYSE American listing compliance. The company also corrected a prior press release error, clarifying that Impact stockholders will receive one share of Zoar Limited for each share of Impact common stock held after the reverse split, not one-for-four as previously stated. However, the company cautioned that there is no assurance the reverse split will achieve listing compliance or that the merger will be completed.

• · The reverse stock split was authorized by stockholders on December 30, 2025, with a ratio range of 1-for-12.48 to 1-for-50, and the exact ratio of 1-for-12.62 was set at the CEO's discretion.
• · No fractional shares will be issued; fractional shares will be rounded up to the nearest whole share.
• · The reverse split does not affect the total number of authorized shares.
• · The merger is expected to result in a pharmaceutical company focused on Active Pharmaceutical Ingredients and intermediates for special therapeutic treatment areas.
• · The corrected press release was issued to fix an error in the September 11, 2026 press release regarding the merger exchange ratio.

15-09-2026

GPO Plus, Inc. filed a Form NT 10-Q on September 14, 2026, indicating it will be unable to file its quarterly report for the period ended July 31, 2026 by the prescribed due date of September 14, 2026. The delay is attributed to needing additional time to complete certain disclosures and analyses. The company expects to file the report on or before the fifth calendar day following the due date and does not anticipate any significant change in results of operations from the comparable prior-year period.

• · All other periodic reports required under Section 13 or 15(d) during the preceding 12 months have been filed.
• · The company does not anticipate any significant change in results of operations from the corresponding prior-year period.
• · The filing was signed by Brett H. Pojunis, President and Chief Financial Officer (principal executive officer and principal financial and accounting officer).

15-09-2026

TORM plc announced a secondary public offering of 9,000,000 Class A common shares by OCM Njord Holdings S.à r.l., a shareholder indirectly owned by Oaktree Capital Management funds. The selling shareholder will grant the underwriter a 30-day option to purchase up to an additional 1,350,000 shares. The company will not receive any proceeds from the offering.

• · The offering is being made under an effective shelf registration statement on Form F-3 (File No. 333-283943).
• · The underwriter may change the public offering price at any time without notice.
• · The company is not selling any shares and will not receive any proceeds.

15-09-2026

Gran Tierra Energy Inc. is seeking stockholder approval for the sale of substantially all of its property and assets via a Share Purchase Agreement, with a Special Meeting scheduled for October 9, 2026. The Board unanimously recommends voting 'FOR' the Sale Proposal, the advisory Compensation Proposal, and the Adjournment Proposal. The filing does not disclose the purchase price or financial projections, but highlights that the sale is subject to majority stockholder approval and other customary conditions.

• · Special Meeting to be held virtually on October 9, 2026 at 10:00 a.m. Mountain Time.
• · Record date for voting is September 14, 2026.
• · Approval of the Sale Proposal requires affirmative vote of a majority of outstanding shares.
• · The Compensation Proposal is advisory and non-binding.
• · The Board unanimously recommends voting FOR all three proposals.
• · No appraisal or dissenters' rights are available to stockholders.
• · A break fee and deposit provisions are included in the Share Purchase Agreement.
• · The financial advisor, BofA Securities, Inc., provided a fairness opinion (attached as Annex B).

15-09-2026

Haymaker Acquisition Corp V filed an S-1/A registration statement on September 14, 2026, for an IPO of 25,000,000 units at an assumed price of $10.00 per unit, with each unit consisting of one Class A ordinary share and one-third of one warrant. The sponsor paid $25,000 for 5,750,000 founder shares in December 2025. The offering includes a potential over-allotment option and a private placement of 5,333,333 warrants to underwriters.

• · Warrant exercise price is $11.50 per share, subject to adjustments.
• · Warrants become exercisable 30 days after completion of initial business combination.
• · Warrants expire five years after completion of initial business combination.
• · Redemption of warrants at $0.01 per warrant if Class A ordinary shares close at or above $18.00 per share for 20 trading days within a 30-trading day period.
• · Founder shares automatically convert into Class A ordinary shares on a one-for-one basis upon business combination.
• · Up to 937,500 founder shares may be surrendered for no consideration depending on over-allotment exercise.

15-09-2026

Asia Pacific Wire & Cable Corporation Ltd filed a Form 6-K with the SEC on September 14, 2026, attaching a press release issued the same day. The filing is a routine foreign private issuer report under Rule 13a-16, signed by Acting CFO Brian Ma. No specific financial results or material events are disclosed in the filing body.

• · Filing type: Form 6-K (Report of Foreign Private Issuer)
• · Commission file number: 1-14542
• · Address: 15/Fl. B, No. 77, Sec. 2, Dunhua South Road, Taipei, 106, Taiwan, R.O.C.
• · Filing covers the month of September 2026
• · Press release dated September 14, 2026, is attached as Exhibit 99.1 but not included in the text.

15-09-2026

Strive, Inc. announced on September 14, 2026 that its board of directors maintained the annual dividend rate on its SATA preferred stock at 13.00%, effective for periods beginning on or after October 1, 2026. The company declared daily cash dividends of $0.0516 per share (aggregating $1.0836 for the full monthly period) for each business day from October 1 through October 31, 2026, with payments scheduled on 21 business days. The company noted it has no accumulated earnings and profits and does not expect to generate current earnings and profits in the current year or foreseeable future, meaning distributions are expected to be treated as tax-deferred returns of capital for U.S. investors and exempt from U.S. dividend withholding tax for non-U.S. investors.

• · Dividend payments are scheduled from October 1, 2026 through October 30, 2026, with record dates on the preceding business day.
• · The company has no accumulated earnings and profits and does not expect to generate current earnings and profits in the current year or the foreseeable future.
• · Distributions are expected to be treated as tax-deferred recovery of capital for U.S. investors and exempt from U.S. dividend withholding tax for non-U.S. investors.

15-09-2026

News Corp filed an 8-K on September 15, 2026, disclosing its daily repurchase activity under its existing $1 billion stock buyback program, as required by Australian Securities Exchange (ASX) rules. The company reiterated its ongoing authorization to repurchase up to $1 billion in aggregate of its Class A and Class B common stock, but no specific repurchase amounts or changes to the program were reported in this filing.

• · The filing is a routine disclosure of repurchase program transactions provided to the ASX, attached as Exhibits 99.1 and 99.2.
• · The repurchase program authorization remains unchanged at $1 billion in aggregate for Class A and Class B common stock.
• · The company disclaims any obligation to update forward-looking statements except as required by law.

15-09-2026

SkyView Investment Advisors, LLC filed its Form 13F-HR for the quarter ended June 30, 2026, disclosing a portfolio of 278 equity holdings with a total market value of approximately $127.7 million. The filing shows a heavy concentration in SPACs and special purpose acquisition companies, with top positions including M3-Brigade Acquisition V-A ($6.3M), New Providence Acquisition-A ($5.0M), and Berto Acquisition Corp ($4.5M). The portfolio also includes significant positions in large-cap tech such as NVIDIA ($3.0M), Amazon ($1.7M), and Alphabet ($1.4M), alongside a large $4.4M position in JPMorgan Chase Financial. However, many holdings have zero market value, including warrants and certain equity stakes, indicating speculative or distressed positions.

• · The filing includes 278 equity holdings with a total market value of approximately $127.7 million.
• · The portfolio is heavily concentrated in SPACs and special purpose acquisition companies, with many positions having zero market value (e.g., warrants, certain equity stakes).
• · Top holdings include M3-Brigade Acquisition V-A ($6.3M), New Providence Acquisition-A ($5.0M), Berto Acquisition Corp ($4.5M), JPMorgan Chase Financial ($4.4M), and Dynamix Corp ($4.0M).
• · Large-cap tech positions include NVIDIA ($3.0M), Amazon ($1.7M), Alphabet ($1.4M), Apple ($0.6M), Microsoft ($0.8M), and Meta Platforms ($0.2M).
• · The filing also includes positions in fixed income ETFs (iShares iBond 2026 HY & Inc $1.7M, iShares iBonds Dec 2027 Term $1.1M) and commodity ETFs (SPDR Gold Trust $2.3M, iShares Silver Trust $0.8M).
• · Many holdings have zero market value, including warrants and certain equity stakes, indicating speculative or distressed positions.
• · The filing was signed by Lawrence Chiarello, Chief Compliance Officer, on July 14, 2026.

15-09-2026

NOVONIX Ltd filed a Form 6-K with the SEC on September 15, 2026, attaching an Appendix 2A application for quotation of securities. The filing, signed by CEO Mike O'Kronley, indicates the company is seeking to list additional securities on the Australian Securities Exchange (ASX). No financial results or operational metrics were disclosed in this filing.

• · The filing is a routine application for quotation of securities (Appendix 2A) under ASX listing rules.
• · No specific number of securities, pricing, or use of proceeds was disclosed in the 6-K.

15-09-2026

Impact Biomedical Inc. announced a 1-for-12.62 reverse stock split effective September 23, 2026, reducing outstanding shares from ~107.8 million to ~8.5 million. The split is intended to support its proposed merger with Zoar Limited and regain NYSE American listing compliance, but the company cautioned there is no assurance it will achieve either goal.

• · The reverse split ratio of 1-for-12.62 was set by the CEO within a previously authorized range of 1-for-12.48 to 1-for-50.
• · Fractional shares will be rounded up to the nearest whole share.
• · Proportional adjustments will be made to equity awards and reserved shares.
• · The authorized share count will not change.
• · At closing of the proposed merger, Impact stockholders will receive one share of Zoar Limited for each post-split share held.
• · A registration statement on Form F-4 has been filed with the SEC by Zoar Limited.

15-09-2026

Northern Dynasty Minerals Ltd. filed an amended annual report (Form 40-F/A) on September 15, 2026, incorporating its Annual Information Form, audited consolidated financial statements for fiscal years 2025 and 2024, and Management's Discussion and Analysis. The filing includes certifications, consents from independent auditors and qualified technical experts, and a compensation recovery policy. No specific financial figures or performance metrics were disclosed in this exhibit index, so no period-over-period comparisons are available.

• · The filing is an amendment (40-F/A) to the annual report, indicating a revision to the previously filed Form 40-F.
• · The audited financial statements cover fiscal years ended December 31, 2025 and 2024, with an independent auditor's report on internal control over financial reporting as of December 31, 2025.
• · The filing includes a Policy for the Recovery of Erroneously Awarded Incentive-Based Compensation (Exhibit 97.1), reflecting compliance with compensation clawback requirements.
• · Consents from 10 qualified technical experts (P.E., P.Eng., P.Geo., PhD) are included, indicating reliance on technical reports for mineral project disclosures.
• · The filing includes certifications by the CEO and CFO under Sections 302 and 906 of the Sarbanes-Oxley Act.

15-09-2026

Tyra Biosciences, Inc. (TYRA) announced a public offering on September 14, 2026, consisting of 9,079,000 shares of common stock at $22.03 per share and pre-funded warrants to purchase 9,078,529 shares at $22.029 per warrant. The gross proceeds are expected to be approximately $400.0 million, before underwriting discounts and expenses. The offering is expected to close on September 15, 2026.

• · The offering is being made under the company's shelf registration statement on Form S-3 (Registration Statement No. 333-298911).
• · Pre-funded warrants have an exercise price of $0.001 per share, are immediately exercisable, and do not expire.
• · Beneficial ownership limitations of 4.99%, 9.99%, or 19.99% apply to the pre-funded warrants, selectable by the holder.
• · The underwriting agreement includes customary representations, warranties, closing conditions, and indemnification obligations.

15-09-2026

Cardiol Therapeutics Inc. filed a Form 6-K with the SEC for September 2026, attaching its Code of Conduct and Ethics as Exhibit 99.1. No financial results, material events, or forward-looking statements were disclosed in this filing.

• · The filing is a routine foreign private issuer report under Rule 13a-16 or 15d-16.
• · No financial data, material developments, or operational updates were included in the filing.

15-09-2026

YPF announced the closing of a transaction in which its wholly-owned subsidiary VMI assigned a 20% interest in the 'La Escalonada' and 'Rincón La Ceniza' Vaca Muerta joint venture contracts to Pluspetrol S.A. As a result, VMI’s retained interest in the contracts reduced to 25%. The filing provides no financial terms or performance data, making it a purely structural update.

• · Closing date was September 14, 2026, following conditions precedent satisfaction.
• · Contracts relate to the 'La Escalonada' and 'Rincón La Ceniza' areas in the Neuquén Province, Argentina.
• · Earlier communications on the transaction were dated January 22 and April 30, 2026.

15-09-2026

Grupo Aval Acciones y Valores S.A. announced the timely payment of interest on its Eighth Issuance of Notes in the Colombian market, fulfilling its obligations under the offering memorandum. The filing reports no new business developments, financial results, or operational changes.

• · Interest payment was made for the Eighth Issuance of Notes in pesos in the Colombian market.
• · Payment was made as per the terms of the offering memorandum.
• · Notice was dated September 14, 2026.